109 related articles for article (PubMed ID: 28133609)
1. Laboratory Genetic Testing in Clinical Practice 2016.
Cogulu O; Schoumans J; Toruner G; Demkow U; Karaca E; Durmaz AA
Biomed Res Int; 2017; 2017():5798714. PubMed ID: 28133609
[No Abstract] [Full Text] [Related]
2. Should oncologists be aware in their clinical practice of KRAS molecular analysis?
Santini D; Galluzzo S; Gaeta L; Zoccoli A; Riva E; Ruzzo A; Vincenzi B; Graziano F; Loupakis F; Falcone A; Muda AO; Tonini G
J Clin Oncol; 2011 Mar; 29(8):e206-7; author reply e208-9. PubMed ID: 21263083
[No Abstract] [Full Text] [Related]
3. Genetic testing: Clinical labs face challenges in oligo management.
Wenter P
MLO Med Lab Obs; 2017 Mar; 49(3):32. PubMed ID: 29924570
[No Abstract] [Full Text] [Related]
4. How will the FDA impact the laboratory developed test?
Davis J; Wentz J
Clin Lab Sci; 2007; 20(3):130-1. PubMed ID: 17691668
[No Abstract] [Full Text] [Related]
5. Special Report: Chromosomal Microarray for the Genetic Evaluation of Patients With Global Developmental Delay, Intellectual Disability, and Autism Spectrum Disorder.
Blue Cross Blue Shield Asssociation
Technol Eval Cent Assess Program Exec Summ; 2015 Aug; 30(2):1-4. PubMed ID: 26376503
[No Abstract] [Full Text] [Related]
6. [Mutational analysis of KRAS prior to targeted therapy in colorectal cancer. Quality control of molecular pathological methods in Sweden].
Enlund F; Helenius G; Palmqvist R; Edsjö A; Sundström M
Lakartidningen; 2010 Feb 3-9; 107(5):255-9. PubMed ID: 20297566
[No Abstract] [Full Text] [Related]
7. High Resolution Melting Analysis (HRMA) for the identification of a rare UGT1A1 promoter polymorphism.
Minucci A; Mello E; Tripodi D; Concolino P; Zuppi C; Capoluongo E
Clin Biochem; 2011 Nov; 44(16):1359-60. PubMed ID: 21889933
[No Abstract] [Full Text] [Related]
8. Screening for colorectal cancer by stool DNA analysis.
Lancet; 1992 May; 339(8802):1141-2. PubMed ID: 1349371
[No Abstract] [Full Text] [Related]
9. [Genetic diagnosis for general practice. What the general practitioner can decipher from genes].
Stiefelhagen P
MMW Fortschr Med; 2001 Mar; 143(10):4-8. PubMed ID: 11268739
[No Abstract] [Full Text] [Related]
10. The impact of human copy number variation on a new era of genetic testing.
Choy KW; Setlur SR; Lee C; Lau TK
BJOG; 2010 Mar; 117(4):391-8. PubMed ID: 20105165
[TBL] [Abstract][Full Text] [Related]
11. On the advent of MSI testing of all colorectal cancers and a substantial part of other Lynch syndrome-related neoplasms.
Dinjens WN; van Leerdam ME; Wagner A
Expert Rev Mol Diagn; 2010 May; 10(4):381-4. PubMed ID: 20465492
[No Abstract] [Full Text] [Related]
12. Single molecules meet genomics: pinpointing precision medicine.
Xie XS
JAMA; 2015 May; 313(20):2021-2. PubMed ID: 25974149
[No Abstract] [Full Text] [Related]
13. Evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review).
England JD; Gronseth GS; Franklin G; Carter GT; Kinsella LJ; Cohen JA; Asbury AK; Szigeti K; Lupski JR; Latov N; Lewis RA; Low PA; Fisher MA; Herrmann D; Howard JF; Lauria G; Miller RG; Polydefkis M; Sumner AJ; ; ;
Muscle Nerve; 2009 Jan; 39(1):116-25. PubMed ID: 19086068
[TBL] [Abstract][Full Text] [Related]
14. Genomic testing and precision medicine--What does this mean for gynecologic oncology?
Liu J; Konstantinopoulos PA; Matulonis UA
Gynecol Oncol; 2016 Jan; 140(1):3-5. PubMed ID: 26657840
[No Abstract] [Full Text] [Related]
15. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
[TBL] [Abstract][Full Text] [Related]
16. RAS testing in metastatic colorectal cancer: excellent reproducibility amongst 17 Dutch pathology centers.
Boleij A; Tops BB; Rombout PD; Dequeker EM; Ligtenberg MJ; van Krieken JH;
Oncotarget; 2015 Jun; 6(17):15681-9. PubMed ID: 25944693
[TBL] [Abstract][Full Text] [Related]
17. [Is it possible to eradicate inherited polyposis coli in colorectal cancer by using genetic diagnosis].
de la Chapelle A
Duodecim; 1996; 112(15):1365-8. PubMed ID: 10596118
[No Abstract] [Full Text] [Related]
18. Autism spectrum disorder: When biochemical and genetic profiles don't match - is sample size and selection bias the culprit?
Kavsak PA
Clin Biochem; 2011 Nov; 44(16):1358. PubMed ID: 21939651
[No Abstract] [Full Text] [Related]
19. College of American Pathologists' laboratory standards for next-generation sequencing clinical tests.
Aziz N; Zhao Q; Bry L; Driscoll DK; Funke B; Gibson JS; Grody WW; Hegde MR; Hoeltge GA; Leonard DG; Merker JD; Nagarajan R; Palicki LA; Robetorye RS; Schrijver I; Weck KE; Voelkerding KV
Arch Pathol Lab Med; 2015 Apr; 139(4):481-93. PubMed ID: 25152313
[TBL] [Abstract][Full Text] [Related]
20. [Colorectal cancer: when and how to look for hereditary nonpolyposis colorectal neoplasm syndrome?].
Jaïs P
Gastroenterol Clin Biol; 1999 Feb; 23(2):284-6. PubMed ID: 10353029
[No Abstract] [Full Text] [Related]
[Next] [New Search]
